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Successful treatment by exchange transfusion of a 
young infant with sodium nitroprusside poisoning
Although sodium nitroprusside (SNP) is often used in pediatric 
intensive care units, cyanide toxicity can occur after SNP treatment. To 
treat SNP-induced cyanide poisoning, antidotes such as amyl nitrite, 
sodium nitrite, sodium thiosulfate, and hydroxycobalamin should be 
administered immediately after diagnosis. Here, we report the first 
case of a very young infant whose SNP-induced cyanide poisoning 
was successfully treated by exchange transfusion. The success of this 
alternative method may be related to the fact that exchange transfusion 
not only removes the cyanide from the blood but also activates 
detoxification systems by supplying sulfur-rich plasma. Moreover, 
exchange transfusion replaces cyanide-contaminated erythrocytes 
with fresh erythrocytes, thereby improving the blood’s oxygen carrying 
capacity more rapidly than antidote therapy. Therefore, we believe that 
exchange transfusion might be an effective therapeutic modality for 
critical cases of cyanide poisoning.
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Introduction
The sodium nitroprusside (SNP) is often used in pediatric 
intensive care units because of its strongly antihypertensive 
properties
1) and various pharmacokinetic advantages
2). However, 
cyanide toxicity, the most lethal complication, can occur after SNP 
treatment. Antidotal therapy is the treatment of choice in cases of 
cyanide poisoning. In general, exchange transfusion can be useful 
in poisoning cases because it activates the detoxification systems and 
removes some of the toxic agents from the blood more rapidly than 
does antidote therapy. Here, we report the first case of a 2-month-
old infant whose SNP-induced cyanide poisoning was successfully 
treated by exchange transfusion rather than by the use of antidotes.
Case report
A 2-month-old male infant was brought to the emergency room 
due to cough, fever, and dyspnea. At the time of presentation to the 
emergency room, the following vital signs were recorded: blood 
pressure, 95/40 mmHg; pulse rate, 187/min; respiration rate, 66/
min; and body temperature, 37.8℃. Oxygen saturation was 80% 
in room air. A chest X-ray revealed consolidation in the right lung. 
Venous blood gas analysis showed the following results: pH, 7.23; 
carbon dioxide partial pressure (pCO2), 65 mmHg; and oxygen 
partial pressure (pO2), 18 mmHg. The white blood cell (WBC) 
count and hemoglobin level were 8,300/mm
3 and 10.7 g/dL, 
respectively. The C-reactive protein (CRP) level was markedly 
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increased (111 mg/L). The infant developed serious dyspnea and 
failed to maintain oxygen saturation; he subsequently underwent 
mechanical ventilation after being hospitalized in the intensive care 
unit. He was diagnosed to have aspiration pneumonia and was 
treated with antibiotics and an anti-inflammatory dose of steroids. 
Several hours after admission, his blood pressure increased to 
110/70 mmHg. To control his blood pressure, treatment with 
nitroglycerin was started. However, 2 days after admission, the 
infant’s blood pressure further increased to 120/80 mmHg after 
methylprednisolone pulse therapy, which was administered to 
control pneumonia that had worsened and progressed to acute 
respiratory distress syndrome. Despite nitroglycerin infused to 
its maximal level, the infant’s blood pressure failed to normalize. 
Thus, SNP was started and maintained with 2.4 μg/(kg · min) until 
SNP-induced cyanide poisoning was diagnosed (on the ninth day 
of hospitalization). In an evaluation study for hypertension, there 
was no evidence of kidney or heart disease. On the seventh day 
after admission, extubation was performed, and arterial blood gas 
analysis finding was within the normal range. By the eighth day 
of hospitalization, SNP continued to be infused at a rate of 2 μg/
(kg· min), and arterial blood gas analysis revealed high anion gap 
metabolic acidosis with compensatory respiratory alkalosis (pH, 
7.44; pCO2, 19 mmHg; pO2, 120 mmHg; and bicarbonate level, 
11 mmol/L); however, respiratory distress symptoms were not 
observed. 
However, 1 day later, on the ninth day of admission, the 
respiratory rate increased gradually, and the patient showed 
symptoms of air hunger, moaning sound, nasal flaring, and 
irritability. The heart rate increased to 190/min. And the patient 
had myoclonic seizures. The infant’s skin was cherry-red in color, 
and arterial blood gas analysis revealed a worsening of the high 
anion gap metabolic acidosis (pH, 7.27; pCO2, 12 mmHg; pO2, 
281 mmHg; and bicarbonate level, 5 mmol/L). Although the 
plasma lactic acid level exhibited a marked increase to 122 mmol/L, 
lung sounds were normal, and a chest X-ray revealed improvement 
in the pneumonic infiltration. No evidence of sepsis or severe 
sepsis was found; there was no fever, normal WBC count (7,280/
mm
3) and hypertension rather than hypotension. The infection 
or inflammation was controlled (CRP was markedly decreased to 
3.5 mg/dL). Thus, SNP toxicity was diagnosed, and SNP infusion 
was stopped. Since a suitable antidote drug was not available, we 
performed an exchange transfusion immediately after SNP toxicity 
was diagnosed. After one volume of exchange transfusion, the 
acidosis improved to a pH of 7.44, a pCO2 of 25 mmHg, a pO2 
of 118 mmHg, and a bicarbonate level of 17 mmol/L. However, 
tachypnea was still observed and the pCO2 level was low. Plasma 
lactate was markedly decreased but not yet normalized (40 mmol/
L). Consequently, a second volume of exchange transfusion was 
administered. Thereafter, the blood gas and plasma bicarbonate 
levels normalized (pH, 7.43; pCO2, 35 mmHg; and bicarbonate 
level, 23 mmol/L), plasma lactate was further decreased (31 mmol/
L), the respiratory rate stabilized, and the patient improved clinically 
(Fig. 1). The infant was discharged from the hospital on the 20th 
day after hospitalization without any neurological deficits. 
Discussion
Although SNP has been used safely to treat many neonates
3), 
infants
4) and children
5), cyanide intoxication should be considered 
if unexplained tachypnea, tachycardia, lactic acidosis, irritability, 
and seizures occur after SNP administration
6). Reported risk 
factors associated with cyanide toxicity from SNP administration 
include prolonged infusion duration and/or high doses of SNP
7), 
as indicated by several cases of cyanide toxicity in patients who had 
received more than 2 μg/(kg·min) SNP or had been infused for 
more than 24 hours
5, 8). Moreover, children and neonates may be 
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Fig. 1. Changes in vital signs and blood gas analysis findings during 
hospitalization. Sodium nitroprusside poisoning was diagnosed after 
9 days of hospitalization. At that time, the patient showed unexplained 
tachypnea, tachycardia, irritability, and seizures. PaO2 was extremely 
high and PaCO2 was lower than the normal range. The plasma lactic 
acid level exhibited a marked increase to 122 mmol/L. These were 
recognized as the classical symptoms and signs of cyanide toxicity. 
The patient was stabilized after exchange transfusion. Abbreviations: 
HR, heart rate; RR, respiratory rate; BT, body temperature; BP, blood 
pressure; PaO2, partial arterial oxygen pressure; PaCO2, partial arterial 
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more susceptible to cyanide toxicity because of lower thiosulfate 
storage levels
9). In the present case, the infant had several risk factors 
for SNP infusion-associated cyanide toxicity; specifically, he was 
very young (2 months old) and had received a high dose [>2 μg/
(kg · min)] of SNP for several days. 
In this case, the infant showed the classical symptoms and signs 
of cyanide toxicity, i.e., tachycardia, tachypnea without respiratory 
problems, unexplained metabolic acidosis, irritability, and seizures. 
It was not possible to measure the blood cyanide concentrations in 
our hospital, but the plasma lactate concentrations were 122 mmol/
L. Plasma lactate concentrations that exceed 10 mmol/L correlate 
with blood cyanide concentrations that exceed 40 μmol/L
10), and 
it has been shown that clinical toxicity appears when the blood 
cyanide concentration exceeds 40 μmol/L
11). In adults, the fatal 
level of cyanide is generally considered to exceed 100-115 μmol/L
10). 
Although nitroglycerin induced lactic acidosis might contribute 
to some portions of the patient’s plasma lactate, his symptoms and 
sings were very typical to cyanide toxicity, we made a diagnosis 
of SNP-induced cyanide toxicity consequently. A key strategy to 
manage cyanide poisoning is to administer sulfur donors; sodium 
thiosulfate is usually used in clinical practice
12). However, antidotes 
were not immediately available to us. Albumin can exhibit enzyme-
like behavior and use bound elemental sulfur to detoxify cyanide
13, 
14). Thus, to supply sulfur donors and remove the cyanide and 
thiocyanate, we performed exchange transfusion. 
Since exchange transfusion activates the detoxification systems 
and can clear some toxins from the blood more rapidly than 
antidotes, it can be useful for poisoning cases. Exchange transfusion 
has been used successfully to treat neonates or infants who have 
been poisoned with salicylate
15), theophyllin
16), phenobarbital
17), 
and other agents. A study in cats revealed that blood exchange 
transfusion is also an effective way to treat acute cyanide 
poisoning
18). While the usefulness of blood exchange transfusion 
for pediatric cases of cyanide or nitroprusside poisoning has not yet 
been reported, we reasonably assumed that exchange transfusion 
would also be efficacious for cyanide poisoning. This is because 
exchange transfusion not only removes cyanide and thiocyanide 
from the blood but also activates the detoxification systems by 
supplying blood with abundant amounts of sulfur moieties. More 
importantly, exchange transfusion replaces cyanide-contaminated 
erythrocytes with fresh erythrocytes, thereby improving the blood’s 
oxygen carrying capacity more rapidly than does antidote therapy. 
Therefore, we believe that exchange transfusion might be an 
effective therapeutic modality in a critical case of cyanide poisoning. 
Cyanide poisoning causes cessation of oxidative phosphorylation 
and induces histotoxic anoxia, especially of the central nervous 
and cardiovascular systems; at high levels, it can lead to death. 
Exchange transfusion causes complications in 5% to 10% of infants 
even though the risk of death from the procedure is only 0.3/100 
procedures
19). In weighing the risks and benefits of using exchange 
transfusion therapy, we considered our patient to be at a serious 
risk from cyanide poisoning (based on classic cyanide poisoning 
signs and a markedly high level of plasma lactate without renal or 
heart problems or evidence of sepsis) and concluded that exchange 
transfusion provided more benefits than risks. Therefore, the infant 
received two rounds of exchange transfusion, after which his plasma 
lactic acid levels dropped markedly, the irritability and seizures 
disappeared, and his blood pCO2 levels and vital signs normalized. 
No complications of exchange transfusion were observed. 
In summary, while exchange transfusion is not considered as 
the primary treatment option for treating SNP infusion-associated 
cyanide poisoning, it may be an effective alternative modality for 
treating this condition if antidotes are not available. 
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